- Home
- ENTA vs HQI Comparison
ENTA vs HQI Comparison
Compare ENTA & HQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTA
- HQI
- Stock Information
- Founded
- ENTA 1995
- HQI 2002
- Country
- ENTA United States
- HQI United States
- Employees
- ENTA N/A
- HQI N/A
- Industry
- ENTA Biotechnology: Pharmaceutical Preparations
- HQI Professional Services
- Sector
- ENTA Health Care
- HQI Consumer Discretionary
- Exchange
- ENTA Nasdaq
- HQI Nasdaq
- Market Cap
- ENTA 164.6M
- HQI 140.2M
- IPO Year
- ENTA 2013
- HQI N/A
- Fundamental
- Price
- ENTA $8.00
- HQI $9.66
- Analyst Decision
- ENTA Strong Buy
- HQI Strong Buy
- Analyst Count
- ENTA 4
- HQI 2
- Target Price
- ENTA $20.75
- HQI $16.00
- AVG Volume (30 Days)
- ENTA 172.2K
- HQI 12.1K
- Earning Date
- ENTA 08-11-2025
- HQI 08-07-2025
- Dividend Yield
- ENTA N/A
- HQI 2.48%
- EPS Growth
- ENTA N/A
- HQI N/A
- EPS
- ENTA N/A
- HQI 0.17
- Revenue
- ENTA $64,806,000.00
- HQI $32,610,000.00
- Revenue This Year
- ENTA N/A
- HQI N/A
- Revenue Next Year
- ENTA $4.05
- HQI $4.99
- P/E Ratio
- ENTA N/A
- HQI $50.61
- Revenue Growth
- ENTA N/A
- HQI N/A
- 52 Week Low
- ENTA $4.09
- HQI $8.94
- 52 Week High
- ENTA $13.43
- HQI $15.75
- Technical
- Relative Strength Index (RSI)
- ENTA 59.48
- HQI 45.73
- Support Level
- ENTA $6.45
- HQI $8.94
- Resistance Level
- ENTA $7.73
- HQI $10.07
- Average True Range (ATR)
- ENTA 0.51
- HQI 0.37
- MACD
- ENTA 0.05
- HQI -0.05
- Stochastic Oscillator
- ENTA 83.33
- HQI 46.15
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.